Literature DB >> 12538645

Compared action of neutrophil proteinase 3 and elastase on model substrates. Favorable effect of S'-P' interactions on proteinase 3 catalysts.

Catherine Koehl1, C Graham Knight, Joseph G Bieth.   

Abstract

Neutrophil proteinase 3 (Pr3) and elastase (NE) may cause lung tissue destruction in emphysema and cystic fibrosis. These serine proteinases have similar P(1) specificities. We have compared their catalytic activity using acyl-tetrapeptide-p-nitroanilides, which occupy the S(5)-S'(1) subsites of their substrate binding site, and intramolecularly quenched fluorogenic heptapeptides, which bind at S(5)-S'(4). Most p-nitroanilide substrates are turned over slowly by Pr3 as compared with NE. These differences disappear with the fluorogenic heptapeptides, some of which are hydrolyzed even faster by Pr3 than by NE. Elongation of substrates strongly increases the catalytic efficiency of Pr3, whereas it has little effect on NE catalysis. These different sensitivities to S'-P' interactions show that Pr3 and NE are not interchangeable enzymes despite their similar P(1) specificity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538645     DOI: 10.1074/jbc.M210074200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

Authors:  Dengfeng Dou; Guijia He; Rongze Kuang; Qingfong Fu; Radhika Venkataraman; William C Groutas
Journal:  Bioorg Med Chem       Date:  2010-08-05       Impact factor: 3.641

3.  Inhibitors of human neutrophil elastase based on a highly functionalized N-amino-4-imidazolidinone scaffold.

Authors:  Guijia He; Dengfeng Dou; Liuqing Wei; Kevin R Alliston; William C Groutas
Journal:  Eur J Med Chem       Date:  2010-06-30       Impact factor: 6.514

4.  A segment of gamma ENaC mediates elastase activation of Na+ transport.

Authors:  Adedotun Adebamiro; Yi Cheng; U Subrahmanyeswara Rao; Henry Danahay; Robert J Bridges
Journal:  J Gen Physiol       Date:  2007-11-12       Impact factor: 4.086

5.  Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents.

Authors:  Qingliang Yang; Yi Li; Dengfeng Dou; Xiangdong Gan; Swathi Mohan; Christopher S Groutas; Laura E Stevenson; Zhong Lai; Kevin R Alliston; Jiaying Zhong; Todd D Williams; William C Groutas
Journal:  Arch Biochem Biophys       Date:  2008-04-22       Impact factor: 4.013

6.  Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides.

Authors:  Yi Li; Qingliang Yang; Dengfeng Dou; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

7.  Mechanism-based inhibitors of serine proteases with high selectivity through optimization of S' subsite binding.

Authors:  Yi Li; Dengfeng Dou; Guijia He; Gerald H Lushington; William C Groutas
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

8.  Utilization of the 1,2,3,5-thiatriazolidin-3-one 1,1-dioxide scaffold in the design of potential inhibitors of human neutrophil proteinase 3.

Authors:  Dengfeng Dou; Guijia He; Yi Li; Zhong Lai; Liuqing Wei; Kevin R Alliston; Gerald H Lushington; David M Eichhorn; William C Groutas
Journal:  Bioorg Med Chem       Date:  2009-12-29       Impact factor: 3.641

9.  X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives.

Authors:  Weijun Huang; Yasufumi Yamamoto; Yi Li; Dengfeng Dou; Kevin R Alliston; Robert P Hanzlik; Todd D Williams; William C Groutas
Journal:  J Med Chem       Date:  2008-03-05       Impact factor: 7.446

10.  Engineering synthetic breath biomarkers for respiratory disease.

Authors:  Leslie W Chan; Melodi N Anahtar; Ta-Hsuan Ong; Kelsey E Hern; Roderick R Kunz; Sangeeta N Bhatia
Journal:  Nat Nanotechnol       Date:  2020-07-20       Impact factor: 40.523

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.